自动化细胞计数市场 - 全球产业规模、份额、趋势、机会及预测（按产品、应用、最终用途、地区和竞争格局划分，2021-2031年）

全球自动细胞计数市场预计将从 2025 年的 41.3 亿美元成长到 2031 年的 86.8 亿美元，复合年增长率达到 13.18%。

这些利用电化学电阻谱和光学影像分析技术对细胞进行定量和活性测定的自动化仪器，正日益取代人工血球计数器。这种增长主要受慢性病发病率上升和生物製药研究范围扩大的推动，而生物製药研究需要精确的细胞分析。例如，美国癌症协会估计，到2024年，美国新增癌症病例将首次超过200万例，日益增长的癌症负担推动了药物研发和临床诊断领域对高效细胞计数技术的需求。

儘管市场有所扩张，但由于高度自动化系统（尤其是采用萤光成像的系统）的高昂购买成本，该市场仍面临许多障碍。小规模的学术实验室和发展中地区的实验室可能难以承担这些购置成本，从而继续依赖人工技术。此外，设备维护和专用耗材的持续支出也会对营运预算造成压力，阻碍其在价格敏感地区的广泛市场渗透。

市场驱动因素

影像分析技术的进步和人工智慧的融合正在显着提高细胞定量分析的准确性和速度，从而变革全球自动化细胞计数市场。现代系统利用机器学习演算法，比传统光学技术更能有效地区分活细胞、死细胞和细胞碎片。这种发展最大限度地减少了人为误差，并确保了不同实验结果的一致性，这对于高通量筛检和复杂的生物鑑定至关重要。 LUNA-III 自动化细胞计数器于 2024 年 9 月上市，正是这一趋势的有力佐证。该产品利用先进的机器学习技术，显着提升了自动对焦和细胞辨识能力，尤其适用于处理各种工作流程中的细胞团块。

同时，在细胞研究和再生医学领域资金投入增加的推动下，生物製药和生技产业蓬勃发展，市场需求也随之成长。随着企业从研发阶段迈向细胞疗法的商业化生产，对检验且符合规范的细胞计数解决方案的需求至关重要，以确保产品的安全性和均一性。根据再生医学联盟（Alliance for Regenerative Medicine）统计，截至2025年1月，全球细胞和基因治疗研发公司数量年增6%，显示此类仪器的基本客群正在不断扩大。这一行业扩张也与临床进展相吻合。国际细胞和基因治疗学会（ISCT）在2025年1月报告称，2024年有七种新型细胞和基因治疗产品获得美国食品药品监督管理局（FDA）核准，证实了其商业性可行性，从而推动了精密分析工具的应用。

市场挑战

自动化细胞计数器的高昂购置成本是限制市场成长的一大障碍。先进的系统，尤其是那些配备萤光检测功能的系统，需要大量的资本投入，这往往超出了发展中地区小规模学术和研究实验室的购买力。这种经济障碍迫使许多机构继续依赖手动血球计数器，而手动血球计数器的通量较低且容易出现人为误差。因此，在那些预算优先用于购买必要试剂而非设备升级的成本敏感市场，自动化解决方案的市场渗透率受到限制，从而影响了其整体普及率。

此外，包括持续维护和专用耗材在内的总拥有成本 (TCO) 也给营运预算带来了额外压力。如果科研经费预计不会增加，这种财务负担会更加沉重。例如，根据美国科学促进会 (AAAS) 的数据，美国国立卫生研究院 (NIH) 2024 财年的联邦预算约为 471 亿美元，这项固定拨款实际上降低了购买力，并因通货膨胀而难以购买新的实验室设备。这些财务限制迫使实验室推迟实施新的自动化系统，直接阻碍了全球市场的收入成长。

市场趋势

随着企业从研发阶段转向大规模商业化生产，开发用于细胞和基因治疗生产的专用解决方案已成为设备製造商的首要任务。这一趋势重新激发了对专用合规硬体的资本投资，以管理复杂的生产流程。与通用实验室设备相比，随着生物技术产业财务压力的缓解和生产能力的提升，这些专用系统正迅速普及。根据ChemoMetec于2024年9月发布的“2024/2025第一季报告”，该公司设备销售额年增61%。这一增长直接归功于细胞和基因治疗公司获得的新资本注入，从而加强了其基础设施建设。

同时，单细胞定序工作流程的广泛应用正在推动市场成长。此应用需要严格的上游工程品管。在单细胞RNA定序（scRNA-seq）中，准确评估细胞活力和浓度至关重要，以避免因试剂和定序运行成本高而导致的代价高昂的实验失败。这种高价值的工作流程持续推动着对能够在下游处理前准确检验样本品质的自动化计数器的需求。例如，10x Genomics在2025年2月发布的「2024年第四季及全年财报」中公布了6.108亿美元的全年营收，凸显了依赖精确细胞计数的大规模单细胞研究活动的重要性。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球自动化细胞计数市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（设备、耗材及配件）
  • 依应用领域（血液分析、干细胞研究、细胞株开发等）
  • 按最终用户划分（製药和生物技术公司、医院和诊断检查室、研究和学术机构、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美自动化细胞数市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲自动化细胞计数市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区自动化细胞计数市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲自动化细胞计数市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲自动化细胞计数市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球自动化细胞计数市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Merck KgaA
• Countstar, Inc.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd
• Chemometec A/S
• Olympus Corporation
• Sysmex Corporation
• Agilent Technologies, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Automated Cell Counting Market is projected to expand from USD 4.13 Billion in 2025 to USD 8.68 Billion by 2031, achieving a compound annual growth rate of 13.18%. These automated instruments, which utilize electrical impedance or optical image analysis to quantify cells and determine viability, are increasingly superseding manual hemocytometers. A primary catalyst for this growth is the rising prevalence of chronic diseases alongside the broadening scope of biopharmaceutical research that necessitates precise cellular analysis. For instance, the American Cancer Society estimates that new cancer diagnoses in the United States will surpass 2 million for the first time in 2024, a burden that intensifies the need for efficient cell counting technologies within drug discovery and clinical diagnostics.

Despite this expansion, the market faces a substantial hurdle due to the high purchase price of advanced automated systems, especially those employing fluorescence imaging. Small-scale academic laboratories and research entities in developing regions often find these capital costs prohibitive, resulting in a persistent dependence on manual techniques. Moreover, the recurring expenses related to instrument maintenance and proprietary consumables can burden operational budgets, a factor that potentially hinders widespread market penetration in price-sensitive regions.

Market Driver

Technological progress in image analysis and the integration of artificial intelligence are transforming the Global Automated Cell Counting Market by markedly enhancing the precision and speed of cellular quantification. Contemporary systems increasingly leverage machine learning algorithms to differentiate between viable cells, dead cells, and debris with a level of accuracy that outperforms traditional optical techniques. This evolution minimizes human error and ensures consistent results across varied experiments, which is essential for high-throughput screening and complex biological assays. As evidence of this trend, Logos Biosystems introduced the LUNA-III automated cell counter in September 2024, deploying advanced machine learning to improve autofocusing and cell recognition, specifically to manage aggregated cells in diverse workflows.

Simultaneously, the growth of the biopharmaceutical and biotechnology industries, fueled by increased funding for cell-based research and regenerative medicine, is driving market demand. As companies progress from research phases to commercial-scale manufacturing of cell therapies, the requirement for validated, regulatory-compliant cell counting solutions becomes critical for ensuring product safety and uniformity. According to the Alliance for Regenerative Medicine, the number of cell and gene therapy developers globally increased by 6% over the past year as of January 2025, highlighting a growing customer base for these instruments. This industrial expansion aligns with clinical progress; the International Society for Cell & Gene Therapy reported in January 2025 that seven new cell and gene therapy products received FDA approval in 2024, confirming the commercial viability that spurs the adoption of precise analytical tools.

Market Challenge

The substantial acquisition costs linked to automated cell counting instruments represent a significant impediment to market growth. Sophisticated systems, especially those capable of fluorescence detection, necessitate a level of capital expenditure that often outstrips the purchasing power of smaller academic laboratories and research institutions in developing areas. This financial hurdle compels many facilities to depend on manual hemocytometers, despite their lower throughput and increased susceptibility to human error. As a result, the market faces difficulties penetrating cost-conscious sectors where budget priorities favor essential reagents over equipment upgrades, thereby restricting the overall rate of adoption for automated solutions.

Additionally, the total cost of ownership, encompassing continuous maintenance and proprietary consumables, exerts further pressure on operational budgets. This economic strain is exacerbated when research funding fails to grow. For example, the American Association for the Advancement of Science noted that the 2024 federal budget for the National Institutes of Health was finalized at roughly 47.1 billion dollars, a flat funding trajectory that effectively diminished purchasing power for new laboratory instrumentation due to inflation. Such fiscal limitations force laboratories to postpone the acquisition of new automated systems, directly hindering revenue expansion within the global market.

Market Trends

The development of specialized solutions for cell and gene therapy manufacturing has emerged as a central priority for instrument manufacturers, spurred by the sector's transition from research to large-scale commercial production. This trend involves a renewed investment in capital expenditure for dedicated, regulatory-compliant hardware designed to manage complex manufacturing workflows. In contrast to general-purpose laboratory equipment, these specialized systems are experiencing rapid adoption as financial pressures within the biotech industry alleviate and manufacturing capabilities grow. According to ChemoMetec's 'Interim Report for Q1 2024/25' from September 2024, the company observed a 61% rise in instrument sales year-over-year, a growth directly linked to the fresh capital infused into cell and gene therapy companies for infrastructure enhancements.

Concurrently, the proliferation of single-cell sequencing workflows is driving market momentum, as this application demands rigorously strict upstream quality control. In single-cell RNA sequencing (scRNA-seq), the substantial costs associated with reagents and sequencing runs make the precise evaluation of cell viability and concentration essential to avoid costly experimental failures. This high-value workflow has generated a persistent demand for automated counters capable of accurately validating sample quality prior to downstream processing. Highlighting the magnitude of this application, 10x Genomics reported in its 'Fourth Quarter and Full Year 2024 Financial Results' in February 2025 that full-year revenue reached 610.8 million dollars, emphasizing the considerable volume of single-cell research activities dependent on accurate cellular enumeration.

Key Market Players

• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Merck KgaA
• Countstar, Inc.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd
• Chemometec A/S
• Olympus Corporation
• Sysmex Corporation
• Agilent Technologies, Inc.

Report Scope

In this report, the Global Automated Cell Counting Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Automated Cell Counting Market, By Product

• Instruments
• Consumables & Accessories

Automated Cell Counting Market, By Application

• Blood Analysis
• Stem Cell Research
• Cell Line development
• Others

Automated Cell Counting Market, By End Use

• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic laboratories
• Research & Academic Institutes
• Others

Automated Cell Counting Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Automated Cell Counting Market.

Available Customizations:

Global Automated Cell Counting Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Automated Cell Counting Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Instruments, Consumables & Accessories)
  • 5.2.2. By Application (Blood Analysis, Stem Cell Research, Cell Line development, Others)
  • 5.2.3. By End Use (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic laboratories, Research & Academic Institutes, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Automated Cell Counting Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Automated Cell Counting Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Automated Cell Counting Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Automated Cell Counting Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End Use

7. Europe Automated Cell Counting Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Automated Cell Counting Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Automated Cell Counting Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Automated Cell Counting Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Automated Cell Counting Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Automated Cell Counting Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End Use

8. Asia Pacific Automated Cell Counting Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Automated Cell Counting Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Automated Cell Counting Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Automated Cell Counting Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Automated Cell Counting Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Automated Cell Counting Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Automated Cell Counting Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Automated Cell Counting Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Automated Cell Counting Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Automated Cell Counting Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End Use

10. South America Automated Cell Counting Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Automated Cell Counting Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Automated Cell Counting Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Automated Cell Counting Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Automated Cell Counting Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Danaher Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Thermo Fisher Scientific Inc.
• 15.3. Merck KgaA
• 15.4. Countstar, Inc.
• 15.5. Bio-Rad Laboratories, Inc.
• 15.6. F. Hoffmann-La Roche Ltd
• 15.7. Chemometec A/S
• 15.8. Olympus Corporation
• 15.9. Sysmex Corporation
• 15.10. Agilent Technologies, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer